RohitBishnoiMD

Oncology • Riverview, FL

Hematologic Oncology

Fellow, Hematology & Oncology, University of Florida

Join to view full profile

Dr. Bishnoi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bishnoi's full profile

Already have an account?

Office
6901 Simmons Loop FL 2
Riverview, FL 33578
Phone+1 813-302-8718

Fax+1 813-605-6021

Summary

Dr. Rohit Bishnoi is a physician in Gainesville, FL and is affiliated with UF Health Shands Hospital. He received his medical degree from Sardar Patel Medical College and has been in practice 14 years. He is currently doing fellowship in hematology oncology.

Education & Training

University of FloridaFellowship, Hematology and Medical Oncology, 2018 - 2021
McLaren Health Care/Flint/MSUResidency, Internal Medicine, 2007 - 2010
Sardar Patel Medical CollegeClass of 2003

Certifications & Licensure

FL State Medical License 2013 - 2026
GA State Medical License 2021 - 2026
NC State Medical License 2023 - 2025
AR State Medical License 2010 - 2018
MI State Medical License 2007 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

1212 citations
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20
3 citations
An innovative resident-driven mortality case review curriculum to teach and drive system-based practice improvements in the United States
Nila S. Radhakrishnan, Margaret C. Lo, Rohit Bishnoi, Subhankar Samal, Robert Leverence
Journal of Educational Evaluation for Health Professions. 2018-12-26
36 citations
Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and En...
Rohit Bishnoi, Young-Rock Hong, Chintan Shah, Azka Ali, William Paul Skelton
Cancer Medicine. 2019-07-01

Lectures

DDP4 inhibitors as novel agents in improving survival in diabetic patients with CRC and lung cancer: A SEER-Medicare study.
2019 ASCO Annual Meeting - 6/1/2019
Bleeding and Thrombotic Risk in Low Dose Heparin Infusion As Compared to Standard Dose Heparin Infusion
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Low Country Cancer Care Opens Clinic in StatesboroJanuary 14th, 2022